Global Retail Healthcare Market

Global Retail Healthcare Market


Global Retail Healthcare Market By Product Type (Retail Owned, Hospital Owned), By Application (Big Box Retailer, Drugstore chain, Grocery chain, Standalone Drug Store) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2020 to 2032

The global Retail Healthcare market was valued at $4.74 Billion in 2022 and is anticipated to grow at a CAGR of 17.64% from 2023 to 2033. This growth is attributed to several macro and microeconomic factors such as

Increasing cost of traditional healthcare services
Surge in healthcare costs significantly influences the growth of the global retail healthcare market. It refers to the continual increase in expenses associated with traditional healthcare services like hospital care and specialized medical procedures. As healthcare costs continue to climb, individuals and families seek cost-effective alternatives for their healthcare needs, particularly for routine and non-emergency care. Retail healthcare providers play a crucial role in addressing this issue. They often offer transparent pricing for their services, allowing consumers to easily compare costs and choose affordable options. These providers focus on basic and routine healthcare services such as vaccinations, minor illness treatment, preventive care, and wellness services, which tend to be less expensive than complex medical procedures or hospital stays. Moreover, the convenience and accessibility of retail healthcare outlets, including walk-in clinics, urgent care centers, and telehealth services within retail settings, reduce the financial and logistical burdens associated with accessing healthcare. Some health insurance plans even offer lower copayments for retail healthcare services, encouraging patients to opt for these more affordable options. Retail pharmacies, a significant component of retail healthcare, often provide prescription drugs at competitive prices, easing the financial strain of medication costs. Additionally, retail healthcare providers emphasize preventive care and chronic disease management, helping patients avoid costly hospitalizations and treatments. Health and wellness programs offered by these providers promote a healthy lifestyle, mitigating the onset of chronic diseases and reducing the need for expensive medical interventions.

Rising aging population

Rise in aging population is a pivotal force behind the growth of the healthcare sector, particularly the retail healthcare sector. This factor signifies the global demographic trend of an increasing proportion of elderly individuals within the population, primarily due to longer life expectancies and declining birth rates. As this aging population grows, there is a corresponding surge in the demand for healthcare services, encompassing routine medical check-ups, preventative healthcare measures, and the management of age-related health issues. Retail healthcare providers are poised to play a critical role in meeting this increased demand. They offer an array of services tailored to the needs of older adults. This includes preventive care and wellness services such as vaccinations, health screenings, and health education programs that are especially pertinent for seniors in preventing or detecting health problems at an early stage. Furthermore, retail healthcare facilities are equipped to manage chronic medical conditions frequently encountered among the aging population. Regular check-ups, medication management, and lifestyle counseling provided by retail healthcare providers contribute significantly to improving the quality of life for seniors. Accessibility is another key advantage of retail healthcare. These outlets, often located within retail settings, are readily accessible to elderly individuals, many of whom may have mobility constraints. This proximity eases the burden of travel and enhances the convenience of accessing healthcare services. For caregivers responsible for the well-being of older family members or patients, retail healthcare offers a convenient avenue for obtaining essential medical services. This is particularly valuable for non-emergency and routine care needs, relieving caregivers of logistical challenges. In addition to healthcare services, retail healthcare providers may offer holistic health services encompassing mental health support, nutritional counseling, and fitness programs tailored for older adults. These services cater to the overall well-being of seniors, acknowledging that health encompasses not only physical but also mental and emotional aspects.

Further several factors restraining the market growth include

Regulatory hurdles and compliance requirements

Healthcare provider encompass the intricate and often demanding regulations and compliance requirements that the retail sector must grapple with. They encompass a wide range of aspects, from licensing and certification to data privacy, billing, and quality standards. The complexity and variability of these regulations across different regions and jurisdictions can create significant hurdles for retail healthcare providers. Obtaining the necessary licenses and certifications can be a time-consuming and costly process, potentially delaying the establishment of new retail healthcare outlets. Moreover, regulations often dictate the scope of practice for healthcare professionals, limiting the services they can offer, which may restrict the ability to cater to diverse patient needs. Compliance with privacy regulations and secure data handling is paramount, given the sensitive nature of healthcare information. Additionally, navigating evolving telehealth regulations, drug pricing, and consumer protection mandates adds layers of complexity. Staying abreast of changing regulations in a dynamic healthcare landscape is essential but challenging. Retail healthcare providers must allocate considerable resources and expertise to successfully navigate these regulatory challenges and operate within legal parameters.

Telehealth integration and collaborations and alliances in the Retail Healthcare market are expected to generate higher avenues during the forecast period.

In the wake of the COVID-19 pandemic, supply chain disruptions have led to supply shortages or lower demand in the Retail Healthcare market. The pandemic has caused a decline in new orders and a corresponding decrease in production.

This section will analyze how COVID-19 has impacted supply chains, leading to shortages and lower demand for Retail Healthcare.

In terms of COVID-19 impact, the Retail Healthcare market report also includes the following data points:

Impact on Retail Healthcare market size
Operating Weights Trend, Preferences, and Budget Impact
Regulatory Framework/Outdoor Policies
Key Players' Strategy to Tackle Negative Impact/Post-COVID Strategies
Opportunity in the Retail Healthcare market

Key Insight in the report:

The global Retail Healthcare market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and Product Types.

Our report covers extensive competitive intelligence which includes the following data points:

Business Overview
Business Segment Data
Financial Data
Product Segment Analysis and Specification
Recent Development and Company Strategy Analysis
SWOT Analysis

Retail Healthcare Market Segmentation:

Product Type
Retail Owned
Hospital Owned
Application
Big Box Retailer
Drugstore chain
Grocery chain
Standalone Drug Store

Region/ Countries Covered:

North America
US
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Australia
India
Japan
South Korea
South East Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of Middle East & Africa

Key Players Analyzed in the Report:

CVS HEALTH
Walgreens Co.
Kaiser Foundation Health Plan, Inc.
NextCare
Rite Aid Corp
The Kroger Co.
Geisinger Health
UnitedHealth Group
Access Health International
BELLIN HEALTH SYSTEMS


CHAPTER 1. Executive Summary
CHAPTER 2. Scope of the Study
2.1. Market Definition
2.2. Market Scope & Segmentation
2.2.1. Objective of Report
CHAPTER 3. Evolve BI Methodology
3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast
CHAPTER 4. Market Insights and Trends
4.1. Value Chain Analysis
4.1.1. Providers of health care
4.1.2. The payers for health care
4.1.3. The producers of healthcare products
4.2. Porter’s Five Forces Analysis
4.2.1. Bargaining Power of Buyers
4.2.2. Bargaining Power of Suppliers
4.2.3. Threat of New Entrant
4.2.4. Threat of Substitute
4.2.5. Industry Rivalry
4.3. COVID-19 Impact and Post COVID Scenario on Retail Healthcare Market
4.3.1. Impact of COVID-19
4.3.2. Government Support and Industry Revival Policies
4.3.3. Measures Taken by Companies to Mitigate Negative Impact
4.3.4. Post COVID Trend
CHAPTER 5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. The increase in the number of retail clinics
5.2.2. The increase in the demand for healthcare services
5.3. Restraints
5.3.1. Inadequate infrastructure for retail clinics
5.4. Opportunity
5.4.1. The unavailability of doctors and the high cost of healthcare
CHAPTER 6. Global Retail Healthcare Market, By Product Type
6.1. Introduction
6.1.1. Retail Owned
6.1.2. Hospital Owned
CHAPTER 7. Global Retail Healthcare Market, By Application
7.1. Introduction
7.1.1. Big Box Retailer
7.1.2. Drugstore chain
7.1.3. Grocery chain
7.1.4. Standalone Drug Store
CHAPTER 8. Global Retail Healthcare Market, By Region
8.1. Introduction
8.2. North America
8.2.1. North America: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)
8.2.2. North America: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.2.3. North America: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.2.4. US
8.2.4.1. US: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.2.4.2. US: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.2.5. Canada
8.2.5.1. Canada: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.2.5.2. Canada: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.2.6. Mexico
8.2.6.1. Mexico: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.2.6.2. Mexico: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3. Europe
8.3.1. Europe: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)
8.3.2. Europe: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.3. Europe: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3.4. U.K.
8.3.4.1. U.K.: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.4.2. U.K.: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3.5. Germany
8.3.5.1. Germany: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.5.2. Germany: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3.6. France
8.3.6.1. France: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.6.2. France: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3.7. Italy
8.3.7.1. Italy: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.7.2. Italy: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3.8. Spain
8.3.8.1. Spain: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.8.2. Spain: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.3.9. Rest of Europe
8.3.9.1. Rest of Europe: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.3.9.2. Rest of Europe: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4. Asia Pacific
8.4.1. Asia Pacific: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)
8.4.2. Asia Pacific: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.3. Asia Pacific: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.4. China
8.4.4.1. China: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.4.2. China: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.5. Japan
8.4.5.1. Japan: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.5.2. Japan: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.6. Australia
8.4.6.1. Australia: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.6.2. Australia: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.7. India
8.4.7.1. India: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.7.2. India: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.8. South Korea
8.4.8.1. South Korea: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.8.2. South Korea: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.9. South East Asia
8.4.9.1. South East Asia: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.9.2. South East Asia: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.4.10. Rest of Asia Pacific
8.4.10.1. Rest of Asia Pacific: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.4.10.2. Rest of Asia Pacific: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.5. Latin America
8.5.1. Latin America: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)
8.5.2. Latin America: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.5.3. Latin America: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.5.4. Brazil
8.5.4.1. Brazil: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.5.4.2. Brazil: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.5.5. Argentina
8.5.5.1. Argentina: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.5.5.2. Argentina: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.5.6. Rest of Latin America
8.5.6.1. Rest of Latin America: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.5.6.2. Rest of Latin America: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.6. Middle East & Africa
8.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)
8.6.2. Middle East & Africa: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.6.3. Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.6.4. Saudi Arabia
8.6.4.1. Saudi Arabia: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.6.4.2. Saudi Arabia: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.6.5. UAE
8.6.5.1. UAE: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.6.5.2. UAE: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.6.6. Egypt
8.6.6.1. Egypt: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.6.6.2. Egypt: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.6.7. South Africa
8.6.7.1. South Africa: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.6.7.2. South Africa: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
8.6.8. Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Market Size and Forecast, By Product Type, 2021 – 2033 ($ Million)
8.6.8.2. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2033 ($ Million)
CHAPTER 9. Competitive Landscape
9.1. Competitior Benchmarking 2023
9.2. Market Share Analysis, 2022
9.3. Key Developments Analysis By Top 5 Companies
9.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
CHAPTER 10. Company Profiles
10.1. CVS HEALTH
10.1.1. Business Overview
10.1.2. Financial Analysis
10.1.2.1. Business Segment Revenue, 2022, $ Million
10.1.3. Product Portfolio
10.1.4. Recent Development and Strategies Adopted
10.1.5. SWOT Analysis
10.2. Walgreens Co.
10.2.1. Business Overview
10.2.2. Financial Analysis
10.2.2.1. Business Segment Revenue, 2022, $ Million
10.2.2.2. Geographic Revenue Mix, 2022 (% Share)
10.2.3. Product Portfolio
10.2.4. Recent Development and Strategies Adopted
10.2.5. SWOT Analysis
10.3. Kaiser Foundation Health Plan, Inc.
10.3.1. Business Overview
10.3.2. Financial Analysis
10.3.3. Product Portfolio
10.3.4. Recent Development and Strategies Adopted
10.3.5. SWOT Analysis
10.4. NextCare
10.4.1. Business Overview
10.4.2. Product Portfolio
10.4.3. Recent Development and Strategies Adopted
10.5. Rite Aid Corp
10.5.1. Business Overview
10.5.2. Product Portfolio
10.5.3. SWOT Analysis
10.6. The Kroger Co.
10.6.1. Business Overview
10.6.2. Financial Analysis
10.6.2.1. Business Segment Revenue, 2022, $ Million
10.6.3. Product Portfolio
10.6.4. Recent Development and Strategies Adopted
10.7. Geisinger Health
10.7.1. Business Overview
10.7.2. Product Portfolio
10.7.3. Recent Development and Strategies Adopted
10.8. UnitedHealth Group
10.8.1. Business Overview
10.8.2. Financial Analysis
10.8.2.1. Business Segment Revenue, 2022, $ Million
10.8.3. Product Portfolio
10.8.4. Recent Development and Strategies Adopted
10.8.5. SWOT Analysis
10.9. Access Health International
10.9.1. Business Overview
10.9.2. Product Portfolio
10.9.3. Recent Development and Strategies Adopted
10.10. BELLIN HEALTH SYSTEMS
10.10.1. Business Overview
10.10.2. Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings